Search by Drug Name or NDC

    NDC 00173-0526-00 LAMICTAL 5 mg/1 Details

    LAMICTAL 5 mg/1

    LAMICTAL is a ORAL TABLET, FOR SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by GlaxoSmithKline LLC. The primary component is LAMOTRIGINE.

    Product Information

    NDC 00173-0526
    Product ID 0173-0526_d15a5607-7757-4f62-9269-154d706b67e9
    Associated GPIs 72600040000510
    GCN Sequence Number 021935
    GCN Sequence Number Description lamotrigine TB CHW DSP 5 MG ORAL
    HIC3 H4B
    HIC3 Description ANTICONVULSANTS
    GCN 64323
    HICL Sequence Number 007378
    HICL Sequence Number Description LAMOTRIGINE
    Brand/Generic Brand
    Proprietary Name LAMICTAL
    Proprietary Name Suffix n/a
    Non-Proprietary Name lamotrigine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FOR SUSPENSION
    Route ORAL
    Active Ingredient Strength 5
    Active Ingredient Units mg/1
    Substance Name LAMOTRIGINE
    Labeler Name GlaxoSmithKline LLC
    Pharmaceutical Class Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA020764
    Listing Certified Through 2024-12-31

    Package

    NDC 00173-0526-00 (00173052600)

    NDC Package Code 0173-0526-00
    Billing NDC 00173052600
    Package 100 TABLET, FOR SUSPENSION in 1 BOTTLE (0173-0526-00)
    Marketing Start Date 1998-09-04
    NDC Exclude Flag N
    Pricing Information N/A